Literature DB >> 28541392

Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al.

J W Gilbert1,2,3, B Wolpin3,4, T Clancy3,5, J Wang3,5, H Mamon3,6, A B Shinagare1,2,3, J Jagannathan1,2,3, M Rosenthal1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28541392      PMCID： PMC6075541          DOI： 10.1093/annonc/mdx273

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  Semin Oncol       Date:  2014-12-08       Impact factor: 4.929

2.  Endoscopic ultrasonography complements computed tomography in predicting portal or superior mesenteric vein resection in patients with borderline resectable pancreatic carcinoma.

Authors:  Evan S Glazer; Omar M Rashid; Jason B Klapman; Cynthia L Harris; Pamela J Hodul; Jose M Pimiento; Mokenge P Malafa
Journal:  Pancreatology       Date:  2016-12-05       Impact factor: 3.996

3.  FDG PET or PET/CT in patients with pancreatic cancer: when does it add to diagnostic CT or MRI?

Authors:  Omar Javery; Paul Shyn; Koenraad Mortele
Journal:  Clin Imaging       Date:  2012-08-24       Impact factor: 1.605

4.  Borderline resectable pancreatic cancer: an evolving concept.

Authors:  N Petrucciani; T Debs; G Nigri; F D'Angelo; J Gugenheim; G Ramacciato
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

Review 5.  Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.

Authors:  J W Gilbert; B Wolpin; T Clancy; J Wang; H Mamon; A B Shinagare; J Jagannathan; M Rosenthal
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.